SCHEMBL10133363

SCHEMBL10133363

COC(=O)c1scc(NC(=O)C2CCC(NS(=O)(=O)C(C)(C)C)CC2)c1C(=O)OC

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPY5R Q15761 1/20 0.46
▸ KDM4E B2RXH2 7/20 0.41
▸ HTT P42858 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ ALDH1A1 P00352 3/20 0.37
▸ BRD4 O60885 2/20 0.37
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HSD17B10 Q99714 4/20 0.36
▸ MAPT P10636 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ KMT2A Q03164 2/20 0.34
▸ TSHR P16473 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13203779 1.00 NPY5R (0.46) NPY5RKDM4EHTTATMALDH1A1
SCHEMBL10114036 0.85 KDM4E (0.40) KDM4EHTTATMALDH1A1BRD4
SCHEMBL13052680 0.83 KDM4E (0.42) KDM4EHTTATMALDH1A1NPC1
SCHEMBL17090473 0.82 KDM4E (0.40) NPY5RKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL13973373 0.79 KDM4E (0.46) KDM4EHTTATMALDH1A1NPC1
SCHEMBL12882752 0.78 NPY5R (0.47) NPY5RALDH1A1BRD4NPC1KMT2A
SCHEMBL10133213 0.73 HTT (0.58) NPY5RHTTALDH1A1RAB9ASMN1; SMN2
SCHEMBL10114315 0.73 HTT (0.58) NPY5RHTTALDH1A1RAB9ASMN1; SMN2
SCHEMBL10114328 0.72 NPY5R (0.55) NPY5RSMN1; SMN2KMT2ATSHRMEN1
SCHEMBL10133393 0.72 NPY5R (0.55) NPY5RSMN1; SMN2KMT2ATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8115027-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2012-02-14 — — US disclosed
US-20110039802-A1 NPY Y5 ANTAGONIST KAWANISHI YASUYUKI 2011-02-17 — — US disclosed
US-7265130-B2 NPY Y5 antagonist SHIONOGI & CO., LTD. (JP) 2007-09-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039802-A1 NPY Y5 ANTAGONIST NPY5R, NPY1R, NPY2R NPY5R 1/4885KDM4E 1653/4885HTT 2095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback